...
首页> 外文期刊>Scrip Regulatory Affairs >Preparing for unannounced medical device inspections in the EU - are you ready?
【24h】

Preparing for unannounced medical device inspections in the EU - are you ready?

机译:准备在欧盟进行未经通知的医疗器械检查-您准备好了吗?

获取原文
获取原文并翻译 | 示例
           

摘要

The long expected European Commission recommendation on audits and assessments performed by notified bodies in the field of medical devices was published on 24 September, together with the commission implementing regulation on designation of notified bodies.Both documents can be seen as output of the immediate action plan initiated by former EU health commissioner John Dalli following the PIP breast implant affair Consequently they will have a short transition period, of only a few months. Whilst the recommendation includes detailed expectations on evaluation of technical files and design dossiers, regular conformity assessment audits as well as situations around own brand labeling, the most critical element of the document is seen as expected unannounced visits, that are to be added to the existing audit structure. Unannounced visits will be essentially different from the well planned pre-scheduled audits.A commission recommendation is a new tool in the EU medical device world. Although it is gently phrased as a request to member states to use the details in identifying their expectations on notified bodies, effectively it can be seen as soft legislation, with a significant legal status. At this stage most member states have already confirmed they will endorse the document and follow it as part of their duty to oversee the work of their notified bodies.Moreover; in support of that effort and, as requested by individual member states, a number of unannounced visits have been performed over the past year.
机译:9月24日,欧洲委员会对医疗器械领域的指定机构进行审计和评估提出了长期期待的建议,并与欧洲委员会实施的指定机构指定法规一起发布。这两个文件都可以视为立即行动计划的输出由前欧盟卫生专员约翰·达利(John Dalli)发起的PIP乳房植入物事件之后,它们的过渡期很短,只有几个月。尽管该建议包括对技术文件和设计文件评估的详细期望,定期的合格评定审核以及自有品牌标签的情况,但文档中最关键的元素被视为预期的未经通知的访问,这些访问应添加到现有文件中审核结构。突击访问将与计划周密的预先计划的审核本质上有所不同。委员会的建议是欧盟医疗器械界的一项新工具。尽管它被轻描淡写地表达为要求成员国使用这些细节来确定其对指定机构的期望,但实际上,它可以被视为具有重要法律地位的软立法。在现阶段,大多数成员国已经确认将批准该文件,并遵循该文件,作为监督其指定机构工作的职责的一部分。为支持这一努力,并应个别成员国的要求,在过去一年中进行了多次突击访问。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号